Statins and Intracranial Aneurysms

Guideline Recommendations

• The American Heart Association/American Stroke Association recommends that statins should not be used to prevent growth or rupture of unruptured intracranial aneurysms, as observational findings do not support their use for prevention, based on the highest quality evidence 1
• The American Heart Association/American Stroke Association explicitly states that while statins may theoretically retard aneurysm formation, observational findings are not supportive of the use of statins for prevention, representing the most authoritative guidance on this specific question and directly addressing intracranial aneurysms 1

Context: Distinction from Other Vascular Conditions

• The American College of Cardiology/American Heart Association notes that for thoracic aortic aneurysms, animal studies have shown reduction in thoracic aneurysm growth with statin therapy, possibly via regulation of MMP activity, and some observational human studies suggest slowing of aortic growth 2, 3
• The American College of Cardiology/American Heart Association explicitly stated that there are no clinical outcomes data that justify statin use to prevent expansion after thoracic aortic aneurysms have developed 4

Clinical Implications

• The American Heart Association/American Stroke Association recommends that statins should not be prescribed with the expectation of preventing intracranial aneurysm growth or rupture, and should only be prescribed for standard indications such as atherosclerotic cardiovascular disease, diabetes, or elevated LDL cholesterol 1